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Abstract
Background: Sindbis virus (SV) is the prototype of alphaviruses which are a group of widely distributed human
and animal pathogens. Heterogeneous nuclear ribonucleoprotein (hnRNP) A1 is an RNA-binding protein that
shuttles between the nucleus and the cytoplasm. Our recent studies found that hnRNP A1 relocates from nucleus
to cytoplasm in Sindbis virus (SV)-infected cells. hnRNP A1 binds to the 5′ UTR of SV RNA and facilitates the viral
RNA replication and translation.
Methods: Making use of standard molecular techniques, virology methods and an in vitro system developed by
our lab to assess the role of hnRNP A1 in SV positive strand RNA synthesis.
Results: hnRNP A1 interacted with the genomic (G) and subgenomic (SG) RNA promoters. Knockdown of hnRNP
A1 resulted in markedly decrease in the synthesis of G and SG RNA both in infected cells and in vitro.
Conclusions: Our study provides the first direct evidence that hnRNP A1 actively participates in viral RNA
replication and is required for the synthesis of G and SG RNA.
Background
Alphaviruses are a group of widely distributed human
and animal pathogens that includes almost 40 currently
known members [1]. In natural conditions, most alpha-
viruses are transmitted by mosquitos that develop life-
long chronic infections [2]. The presence of virus in the
mosquito salivary glands mediates infection of verte-
brates that serve as amplifying hosts. In vertebrates,
alphaviruses develop acute infections characterized by
high-titer viremia that is required for infection of mos-
quitoes during their blood meal. Ultimately, alphavirus
infection of the vertebrate host is either cleared by the
immune system or causes the death of an infected host.
Sindbis virus (SV) is the prototype virus of the family
Togaviridae,g e n u salphavirus [1,3,4]. Sindbis virus has
a non-segmented single-strand RNA genome of positive
polarity, i.e. the genome can function as a messenger
R N A .T h eg e n o m ei s1 1 , 7 0 3n t si nl e n g t h ,h a sa5 ′ type
0 cap and is polyadenylated at its 3′ end.
In the infected cells, SV express only four nonstruc-
tural proteins, namely nsP1, nsP2, nsP3 and nsP4, which
form, together with host factors, the enzyme complex
responsible for the synthesis of virus-specific RNAs [5].
The nsP1 protein was found to have methyltransferase
and guanylyltransferase activity, which are required for
capping the newly synthesized, positive-strand viral
RNAs [6-8]. It is palmitoylated and appears to be mem-
brane-bound [9]. It also plays a role in the regulation of
viral (-) strand RNA synthesis [10], and in the mem-
brane attachment of the replication complex [11]. nsP2
was shown to be an RNA triphosphatase [12], RNA heli-
case [13] and a papain-like protease [14], and is respon-
s i b l ef o rt h ep r o c e s s i n gt h eP 1 2 3a n dP 1 2 3 4
polyproteins into the individual nsPs [3]. In addition,
nsP2 is present not only in the replication complex, but
was also found distributed in the cytoplasm and nuclei
of infected cells [15,16]. nsP3 is the only nsP which is
phosphorylated but its function is not yet clearly
defined. The mutations in this protein can affect RNA
replication, and, based on the structure of the replica-
tion complexes, this protein appears to have a structural
function in the replication complex [17]. nsP4 is an
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sesses terminal adenylyltransferase activity [19].
Upon entry into the cell, the genome is translated into
one of two polyproteins, P123 or P1234. These polypro-
teins are later processed in several steps by a viral pro-
tease into the four nonstructural (ns) proteins, nsP1,
nsP2, nsP3, and nsP4. Initially, a complex of P123
(uncleaved nsP1, nsP2, and nsp3), and nsP4 form an
RNA synthesizing complex that uses the incoming viral
RNA as a template to synthesize a (-) strand RNA
equivalent in length to the viral genome [5,20]. Upon
further processing of the ns polyproteins, an RNA-
synthesizing complex, now consisting of nsP1, nsP2,
nsP3, and nsP4 is formed which uses the (-) strand
RNA as a template to synthesize two (+) strand RNAs, a
genomic (G) RNA, and a subgenomic (SG) RNA which
has the same sequence as the terminal 3′ one third of
the viral genome. The SG RNA serves as the message
for the three structural proteins, the capsid or C protein,
and the two envelope proteins, E1 and E2. Because of
stop codons after the nsP4 coding region, only the four
ns proteins are translated from the G RNA.
In addition to virus-encoded factors, many steps in
virus infections involve host factors. Such virus-host
interactions are crucial determinants of virus host range,
replication, and pathology, offer insights into viral and
cellular function, and provide antiviral targets. Thus
identifying such interactions and the associated host fac-
tors is a major frontier in virology [21,22]. Recently,
using a human-genome-wide RNAi screen Krishnan et
al. [23] have identified 305 host proteins that affect
West Nile virus infection. Functional clustering of these
genes revealed a complex dependence of this virus on a
wide variety of host molecules and cellular pathways in
viral infection. While the viral components of the SV
replicase/transcriptase are known and to some extent
characterized, the cellular proteins involved in viral
RNA synthesis remain poorly understood. Moreover,
while there is also strong evidence that host factors play
a significant role in the activity of the replicase/tran-
scriptase [24,25], the cellular proteins associated with
the alphavirus nsPs and RNA remain to be character-
ized. The first reported interaction between a host pro-
tein and viral RNA was that between the mosquito La
autoantigen and the 3′ end of the SV negative strand
RNA [26]. Recent work by Burnham et al. [27] has
demonstrated that the host protein hnRNP K interacts
with nsP2 and SG RNA in SV-infected cells. Several
reports [17,28,29] have identified other cellular proteins
associated with the SV replicase/transcriptase. These
include cytoskeleton proteins, ribosomal subunits, cha-
perones, and hnRNPs. However, the roles of these cellu-
lar proteins in SV replication remain unclear. hnRNP
A1 was not identified in these studies.
Members of the hnRNP family (including hnRNP A1)
are involved in IRES-dependent translation of cellular
and viral mRNA [30-32]. Moreover, hnRNPs are involved
in several RNA metabolic processes, such as pre-mRNA
splicing and trafficking [33,34] and telomerase regulation
[35]. There is strong evidence that hnRNP A1 plays a cri-
tical role in telomere biogenesis [36]. Interestingly,
hnRNP A1 has been shown to be involved in the replica-
tion of many viruses including mouse hepatitis virus
[MHV], hepatitis C virus [HCV], dengue virus and
human papillomavirus 16 [HPV 16], human cytomegalo-
virus, and vesicular stomatitis virus [VSV] [37-43].
Our recent studies reported that hnRNP A1 plays an
essential role in the replication of SV [44]. hnRNP A1
interacted with the SV 5′UTR and facilitated the transla-
tion of viral RNA. Knockdown of hnRNP A1 reduced
SV RNA synthesis and the yield of progeny virus. In the
present study we extended the experiments on the role
of hnRNP A1 in SV positive strand RNA synthesis. Our
results suggest that hnRNP A1 associated with the geno-
mic (G) and subgenomic (SG) RNA promoters and
enhances the synthesis of G and SG RNA.
Methods
Cells and virus
BSC40 cells were cultured at 37°C in Eagle’sm i n i m u m
essential medium supplemented with 10% fetal calf
serum (FCS) (Mediatech). CEF (chick embryo fibroblast)
cells were grown in Dulbecco’s modified Eagle medium
(DMEM) supplemented with 10% FCS. SV was propa-
gated in CEF cells. Cells were infected with SV at speci-
fied multiplicity of infection (moi) for 1 h at 34°C,
washed away unbound inoculum, and refed with fresh
medium. Media from infected cultures were harvested
at the indicated times, and titers of SV were measured
by plaque formation on CEF cells. Recombinant vaccinia
viruses encoding Sindbis virus P123, nsP4, or T7 poly-
merase (VTF7-3), were kindly provided by Drs. Charles
M. Rice and Richard Hardy and were propagated in
BSC40 cells as described previously [45]. The Sindbis
virus P123 contained the N614D change in nsP2 that
results in more rapid processing of P123 than is
observed with the wt P123[20,46]. The various nsPs
were expressed from a T7 promoter.
Preparation of labeled RNA probes and binding assay
24-mer and 45-mer oligoribonucleotides representing
the negative strand sequence corresponding to nt 7579
to 7602 and nt 1-45 of the SV genome were synthesized
by Dharmacon Research Inc. As already noted, these are
the minimal sequences that have SG and G promoter
activity respectively [47,48]. Oligoribonucleotides were
l a b e l e da tt h e i r5 ′ ends using polynucleotide kinase and
[g-
32P] ATP.
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tion between the promoters and hnRNP A1 as described
previously [47]. Briefly, 2 μgo fh n R N PA 1w a si n c u -
bated for 30 min at 25°C with one of the
32 P-labeled
RNA probes (1×10
4 c.p.m). The reaction was carried out
in binding buffer (10 mM Hepes, pH 7.5/150 mM KCl/
0 . 5m ME G T A / 2m MM g C l 2/1 mM DTT/1 unit RNa-
sin/10% glycerol) and the final volume of the reaction
mixture was 10 μl. Binding of hnRNP A1 to the G and
SG promoters was recognized by a slower migration of
the labeled RNA probes.
Northern blot analysis of G and SG RNA
BSC40 cells were infected with SV at an moi of 40 pfu/
cell and at 8 h post infection total RNA was extracted
using RNeasy mini kit (Qiagen). Five μgo ft o t a lR N A
was denatured with formaldehyde, and electrophoresed
through a 1.5% agarose gel. The RNAs were transferred
to a nylon membrane and subjected to northern blot-
ting. The negative-strand probe, SV7772(-), which con-
tains the negative-strand sequence from nt 7772 to 7754
were end-labeled with
32 P-g-ATP. After hybridization,
the nylon membrane was washed twice with 2 × SSC
and 0.1% SDS, exposed to a storage phosphor screen
and scanned on a Molecular Dynamics Typhoon
Phosphorimager.
Expression and preparation of recombinant Sindbis virus
nonstructural proteins
BSC40 monolayers in T75 tissue culture flasks were
infected with three different recombinant vaccinia virus
vectors; these encode the SV nonstructural polyprotein
P123 (the polyprotein precursor of nsP1, nsP2, and
nsP3), SV nsP4, and T7 RNA polymerase, each at an
moi of one pfu/cell. Twenty to twenty four hours after
infection, the P15 fraction was prepared according to
Lemm et al. [45]. The P15 pellet isolated from one T75
flask was resuspended in 50 μl of storage buffer (10 mM
Tris-Cl [pH 7.8], 10 mM NaCl, 15% glycerol) and used
as the source of the Sindbis virus replicase/transcriptase
(R/T) complex.
In vitro synthesis of SV RNA
The reaction mixture for the in vitro synthesis of SV RNA
(25 μl) contained 5 μl of 5 × reaction buffer (200 mM
Tris-HCl, pH 7.9, 30 mM MgCl2, and 50 mM NaCl),
10 mM dithithreitol, 40 units of RNase inhibitor (Pro-
mega), 2 μg negative-strand RNA which serves as promo-
ter/template (P/T), and 12.2 μl( 5 . 4μgo fp r o t e i n / μl) of
P15 extract prepared from BSC40 cells infected with
recombinant vaccinia viruses expressing the T7 RNA poly-
merase, the SV polyprotein, P123, and the SV nsP4. Stan-
dard reaction mixtures contained 3 mM ATP, 2 mM UTP,
2 mM CTP, and 0.5 mM GTP. [
32P]a-GTP (800 Ci/mM,
10 μCi/μl) was included to label the transcripts. Incubation
was at 37°C for 1 hour. RNA was extracted using phenol-
chloroform and electrophoresed on a 1% denaturing
agarose gel containing 2.2 M formaldehyde. The gel
was transferred to a Genescreen Plus Hybridization
Transfer Membrane (Perkin Elmer); the membrane
was then exposed to a storage phosphor screen and
scanned as described previously [49]. The negative-
strand P/T for making both G and SG RNA was as
described in Li et al. [48].
Expression and purification of recombinant hnRNP A1
protein
hnRNP A1 cDNA derived from SF268 cellular mRNA
was cloned into pET30a and expressed as described
[44]. The recombinant hnRNP A1 protein was purified
using a HisTrap kit (GE). Protein purity was determined
by electrophoresis on 12% SDS-PAGE, and concentra-
tion was determined using the Bio-Rad protein assay.
siRNA knockdown
BSC40 cells were maintained in antibiotic-free media.
100 nmol of siRNA targeting hnRNP A1 (ON-TARGET-
plus SMARTpool L-008221-00-0005, Dharmacon) was
transfected along with 3 μl FuGENE HD transfection
reagent (Roche) in 0.4 ml MEM supplemented with 10%
FCS following manufacturer’s directions. Three days
after transfection cells were co-infected with recombi-
nant vaccinia viruses expressing T7, SV-nsP123 and
SV-nsP4 at an moi of one pfu/cell. P15 fraction was pre-
pared as described [47]. An aliquot of cell lysate was
subject to Western blot for analysis of protein
expression.
Western blotting
Expression of hnRNP A1 was examined by Western
blotting using anti-hnRNP A1 antibody (Abcam). Briefly,
cells were lysed in sample buffer and proteins were frac-
tionated by SDS-PAGE in 12% polyacrylamide gels and
transferred to PVDF membranes by wet transfer. Mem-
branes were blocked with PBS containing 5% low-fat dry
milk. Anti-hnRNP A1 mouse antibody was then added,
and the membranes were washed with PBS containing
0.2% Tween 20. Goat anti-mouse horseradish peroxi-
dase-conjugated antibody (BioRad) and the ECL kit
(Pierce) were used to detect bound antibodies.
Results
hnRNP A1 interacts with the G and SG promoters of
Sindbis virus
Our previous study demonstrated that knockdown of
hnRNP A1 in infected cells reduces the viral RNA
synthesis [44]. To further dissect the role of hnRNP A1
in viral RNA synthesis, we tested if hnRNP A1 is
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acting with the promoters. To learn whether hnRNP A1
interacts with the G and SG promoters, we tested the
binding of hnRNP A 1 to the SV G and SG promoters.
An EMSA was carried out using hnRNP A1 and the
labeled G and SG promoters of Sindbis virus. As shown
in Fig. 1, hnRNP A1 did not bind to a non-specific 31-
mer RNA oligo but did bind to the SV G and SG pro-
moters slowing their electrophoretic mobility. These
results indicate that the interaction between the G and
SG promoters and hnRNP A1 is specific.
hnRNP A1 is required for the synthesis of G and SG RNA
in infected cells
While we have good evidence that hnRNP A1 binds to
the G and SG promoters, the consequences of this
interaction for viral RNA synthesis are not known.
Our recent studies showed that hnRNP A1 re-localizes
from nucleus to cytoplasm of SV-infected cells.
Knockdown of hnRNP A1 inhibits the virus replication
[44]. These findings led us to hypothesize that the
binding of hnRNP A1 to the G and SG promoters is
involved in the regulation of G and SG RNA synthesis
during the virus replication cycle. To assess the role of
hnRNP A1 in viral positive strand RNA synthesis, we
knocked down the expression of hnRNP A1 in
infected cells and examined the synthesis of G and SG
RNA by Northern blot. hnRNP A1 was depleted by
siRNA targeting hnRNP A1 in BSC40 cells as
described previously [44]. Knockdown efficiency was
examined by Western blot using anti-hnRNP A1 anti-
body (Abcam). As shown in Fig. 2A, expression of
hnRNP A1 was diminished in cells transfected with
siRNA targeting hnRNP A1. Cells were then infected
with SV at an moi of 40 pfu/cell for 8 h. Total RNA
was extracted and subject to Northern blot as
described in Materials & Methods. As shown in Fig.
2B, the synthesis of G and SG RNA was dramatically
inhibited when hnRNP A1 was depleted indicating
hnRNP A1 is essential for the positive strand RNA
synthesis. The medium was collected and plaque assay
was carried out to determine the virus titer, as shown
in Fig. 2C, the titer dropped about 4 log in hnRNP A1
knockdown cells.
Figure 1 Binding of hnRNP A1 to the G and SG promoters.
EMSA was performed as described under Material and Methods.
The G and SG promoters were end-labeled with
32PO4 (1 × 10
4
cpm per reaction) and incubated at 37°C for 30 min either alone or
with 2 μg of hnRNP A1. A non-specific 31-mer RNA oligo was end-
labeled with
32PO4 and reacted with 2 μg of hnRNP A1
Figure 2 Effect of hnRNP A1 on the synthesis of G and SG RNA in infected cells. (A) Western blot to examine the expression of hnRNP A1.
hnRNP A1 was depleted by siRNA knockdown technique as described under Materials and Methods. Cell lysates were prepared 3 days after
transfection of siRNA. Western blot was carried out using antibody to hnRNP A1. Expression of actin was examined by Western blot as a control.
(B) Northern blot to detect G and SG RNA in infected cells. Cells were transfected with no siRNA or siRNA targeting hnRNP A1 for 3 days. Cells
were infected with SV at an moi of 40 pfu/cell for 8 h. Total RNA were extracted and electrophoresed through an agarose gel, transferred to a
nylon membrane, and characterized by Northern blot analysis, using
32P-labeled negative-strand probe SV7772(-). (C) Replication of SV in hnRNP
A1-depleted cells. Cells treated or untreated with siRNA targeting hnRNP A1 were infected with SV at an moi. of 40 pfu/cell and incubated at
34°C. Medium was harvested 8 h p.i. and assayed for infectious virus by plaque formation on CEF cells. Mean values and standard errors from
duplicate samples are shown.
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RNA in vitro
We made use of an in vitro system for the synthesis of G
and SG RNA developed by our laboratory [48,49] to exam-
ine the role of hnRNP A1 in the synthesis of G and SG
RNA. Synthesis of the G and SG RNA transcript was fol-
lowed by including
32P-a-labeled GTP in the reaction
mixture, along with the four unlabeled NTPs, the P/T, and
the P15 fraction as described in Materials & Methods.
The level of endogenous hnRNP A1 in BSC40 cells
was knocked down by siRNA targeting of hnRNP A1 as
described in Materials & Methods. The knockdown
efficiency was confirmed by Western blot using
anti-hnRNP A1 antibody (data not shown). The hnRNP
A1-depleted BSC40 cells were then co-infected with
recombinant vaccinia viruses expressing T7 polymerase,
SV P123 and SV nsP4 and the p15 were prepared as
described [47]. As shown in Fig. 3A the expression of
nsP4 in hnRNP A1-depleted cells was as good as in wild
type cells indicating that knockdown of hnRNP A1 did
not affect the expression of the SV nonstructural pro-
teins. To see if knockdown of hnRNP A1 affects G and
SG RNA synthesis in vitro, the reaction was set up as
d e s c r i b e d[ 4 8 ]u s i n ge i t h e rn o r m a lo rh n R N PA 1 -
depleted replicase/transcriptase (P15 fraction) and the
P/T which contains both 5′ and 3′ termini and the SG
promoter region. As shown in Fig. 3B depletion of
hnRNP A1 in BSC40 cells resulted in decreased synth-
esis of both G and SG RNA. Addition of purified
hnRNP A1 back to the hnRNP A1-depleted replicase/
transcriptase was able to restore the RNA synthesis. The
results indicate that hnRNP A1 is required for G and
SG RNA synthesis.
Discussion
Host factors together with viral proteins regulate virus
RNA replication. The finding that mutations in the viral
genome sometimes have different effects in vertebrate
cells and mosquito cells has suggested that cellular fac-
tors play a role in viral RNA synthesis [7]. Recent studies
from several groups have identified cellular proteins asso-
ciated with the SV RNA replication complex by isolating
nonstructural protein-containing complexes from
infected cells [17,27-29]. However, the roles that most of
these proteins play in the replication of SV remain to be
elucidated. Our recent study found that after SV infection
hnRNP A1 relocalized from nucleus to cytoplasm, where
the SV replication occurs. hnRNP A1 was able to bind to
the capped 5′UTR of SV RNA and knockdown of hnRNP
A1 diminished the SV viral RNA and protein synthesis,
cap-dependent translation and viral replication. We
therefore conclude that hnRNP A1 promotes SV replica-
tion via binding to the 5′UTR and facilitates possibly
both viral RNA synthesis and translation [44].
How does hnRNP A1 contribute to the replication of
S V ?A sh n R N PA 1i sa nR N A - b i n d i n gp r o t e i n ,w e
speculated that it might facilitate viral RNA synthesis
via association with viral RNA. In our previous study we
found that hnRNP A1 interacts with the 5′UTR of SV
RNA and promotes the synthesis of negative strand
RNA [[44], data not shown]. In the present study we
demonstrated that hnRNP A1 specifically interacts with
both the G and SG promoters and enhances the synth-
esis of G and SG RNA as knockdown of hnRNP A1 ren-
dered dramatically decrease in the synthesis of these two
RNA species. Taken together we demonstrate that
hnRNP A1 is required for the synthesis of both positive
and negative strand RNA.
Figure 3 Effect of hnRNP A1 on the synthesis of G and SG RNA
in vitro. (A) Western blot to examine the expression of nsP4. BSC40
cells were transfected with no siRNA or siRNA targeting hnRNP A1
for 3 days as described under Materials and Methods. Cells were co-
infected with recombinant vaccinia viruses expressing T7 RNA
polymerase, SV nsP123 and SV nsP4 at an moi of one for 24 h. Cell
lysates were prepared and subjected to 12% SDS-PAGE
electrophoresis. Western blot was carried out using antibody to
nsP4. Expression of actin was examined by Western blot as a
control. (B) in vitro G and SG RNA synthesis. hnRNP A1 was
depleted from BSC40 cells as described above. Cells were co-
infected with recombinant vaccinia viruses expressing T7 RNA
polymerase, SV nsP123 and SV nsP4 and P15 fractions were
prepared as described under Materials and Methods. P/T were
prepared and standard reaction conditions were used as described
under Materials and Methods.
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previous study showed that nsP4, the RDRP, has distinct
sites for the binding of G and SG promoters [47,48].
We therefore suggest that in a similar fashion, hnRNP
A1 also has different sites for the recognition of these
t w op r o m o t e r s .I nf u t u r ew o r kw ei n t e n dt ou s et h e
same procedures that were used to identify the G and
SG promoter binding sites in nsP4 [47] to identify the
binding sites for G and SG promoters in hnRNP A1.
How does hnRNP A1 contribute to the viral RNA
replication? hnRNP A1 is predominantly a nuclear pro-
tein. During SV infection nearly all of hnRNP A1 reloca-
lizes to cytoplasm in association with viral RNA.
Precisely what interactions lead to the recruitment of
hnRNP A1 to the viral RNA replication complex is
unknown. As hnRNP A1 is an RNA-binding protein, it
may direct the viral RNA replication complex containing
the viral RDRP, other viral and cellular factors to the
sites where replication of viral RNA is initiated. More-
over, considering the reported physiological roles of
hnRNP A1, we speculate that hnRNP A1 may interact
with viral nonstructural proteins which comprise the
viral RNA replication complex and facilitates the viral
RNA replication. Further investigation is going on to
address how hnRNP A1 contributes to viral RNA
replication.
To our knowledge, this is the first report to describe
an RNA-binding protein (hnRNP A1) actively participat-
ing in SV RNA replication in molecular detail. These
studies not only improve our understanding of the repli-
cation of SV, but also have the potential for use as the
basis for developing antiviral agents that act by inhibit-
ing the virus RNA replication.
Conclusion
Our previous study and the present report demonstrate
that hnRNP A1 is essential for the RNA replication of
Sindbis virus. hnRNP A1 binds to the 5′ UTR of SV
RNA and facilitates the negative strand RNA synthesis.
Moreover hnRNP A1 interacted with the genomic (G)
and subgenomic (SG) RNA promoters and is required
for the synthesis of G and SG RNA both in infected
cells and in vitro. Our study provides the first direct evi-
dence that hnRNP A1 actively participates in viral RNA
replication and is required for the synthesis of G and
SG RNA.
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